| Assay ID | Title | Year | Journal | Article |
|---|
| AID1454078 | Antibacterial activity against Escherichia coli ATCC 25922 incubated for 18 to 24 hrs by broth microdilution method | 2017 | Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
| Synthesis and structure-activity relationship study of novel quinazolinone-based inhibitors of MurA. |
| AID1501755 | Inhibition of bovine liver beta-glucuronidase using p-nitrophenyl-beta-D-glucuronide as substrate preincubated for 30 mins followed by substrate addition by spectrophotometric analysis | 2017 | European journal of medicinal chemistry, Oct-20, Volume: 139 | Synthesis, in vitro β-glucuronidase inhibitory potential and molecular docking studies of quinolines. |
| AID9011 | Tested in vitro for cytotoxic activity against lung carcinoma (A-549) cell line | 2000 | Journal of medicinal chemistry, Nov-16, Volume: 43, Issue:23
| 6-Alkylamino- and 2,3-dihydro-3'-methoxy-2-phenyl-4-quinazolinones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. |
| AID1312671 | Inhibition of N-terminal GST-tagged human TNKS-2 (849 to 1166 residues) expressed in in insect sf21 cells at 1 uM preincubated for 2 hrs followed by substrate addition measured after 30 mins | 2016 | European journal of medicinal chemistry, Aug-08, Volume: 118 | Structure-activity relationships of 2-arylquinazolin-4-ones as highly selective and potent inhibitors of the tankyrases. |
| AID1866925 | Inhibition of TNKS1 (unknown origin) | 2022 | Journal of medicinal chemistry, 04-14, Volume: 65, Issue:7
| Small-Molecule Inhibitors of Tankyrases as Prospective Therapeutics for Cancer. |
| AID1312668 | Inhibition of N-terminal GST-tagged human TNKS-2 (849 to 1166 residues) expressed in in insect sf21 cells preincubated for 2 hrs followed by substrate addition measured after 30 mins | 2016 | European journal of medicinal chemistry, Aug-08, Volume: 118 | Structure-activity relationships of 2-arylquinazolin-4-ones as highly selective and potent inhibitors of the tankyrases. |
| AID1254450 | Inhibition of Saccharomyces cerevisiae alpha-glucosidase for 15 mins by multiplate reader method using 0.7 mM p-nitrophenyl-alpha-D-glucopyranoside as substrate | 2015 | Bioorganic & medicinal chemistry, Dec-01, Volume: 23, Issue:23
| 2-Arylquinazolin-4(3H)-ones: A new class of α-glucosidase inhibitors. |
| AID1525654 | Inhibition of tankyrase 1/2 in human DLD1 cells assessed as increase in axin2 accumulation incubated for 24 hrs by luminex based bead assay | 2019 | Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
| Discovery and Optimization of 2-Arylquinazolin-4-ones into a Potent and Selective Tankyrase Inhibitor Modulating Wnt Pathway Activity. |
| AID78820 | Tested in vitro for cytotoxic activity against ileocecal carcinoma (HCT-8) cell line | 2000 | Journal of medicinal chemistry, Nov-16, Volume: 43, Issue:23
| 6-Alkylamino- and 2,3-dihydro-3'-methoxy-2-phenyl-4-quinazolinones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. |
| AID84375 | Tested in vitro for cytotoxic activity against bone(HOS) cell line | 2000 | Journal of medicinal chemistry, Nov-16, Volume: 43, Issue:23
| 6-Alkylamino- and 2,3-dihydro-3'-methoxy-2-phenyl-4-quinazolinones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. |
| AID213904 | Tested in vitro for cytotoxic activity against glioblastoma (U-87-MG) cell line;NA means not active. | 2000 | Journal of medicinal chemistry, Nov-16, Volume: 43, Issue:23
| 6-Alkylamino- and 2,3-dihydro-3'-methoxy-2-phenyl-4-quinazolinones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. |
| AID1664158 | Displacement of [3H]DPCPX from Sprague-Dawley rat whole brain membrane A1AR at 100 uM by scintillation counting analysis relative to control | | | |
| AID1312676 | Antiproliferative activity against human HT-29 cells at 1 uM by MTS assay | 2016 | European journal of medicinal chemistry, Aug-08, Volume: 118 | Structure-activity relationships of 2-arylquinazolin-4-ones as highly selective and potent inhibitors of the tankyrases. |
| AID1525653 | Inhibition of recombinant human full-length Myc/His-tagged Parp-1 expressed in baculovirus infected Sf21 insect cells assessed as reduction in auto-PARsylation using activated DNA as substrate incubated for 150 mins in presence of NAD and bio-NAD as co-su | 2019 | Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
| Discovery and Optimization of 2-Arylquinazolin-4-ones into a Potent and Selective Tankyrase Inhibitor Modulating Wnt Pathway Activity. |
| AID214030 | Inhibition of bovine tubulin polymerization | 2000 | Journal of medicinal chemistry, Nov-16, Volume: 43, Issue:23
| 6-Alkylamino- and 2,3-dihydro-3'-methoxy-2-phenyl-4-quinazolinones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. |
| AID1312672 | Inhibition of N-terminal GST-tagged human TNKS-2 (849 to 1166 residues) expressed in in insect sf21 cells at 100 nM preincubated for 2 hrs followed by substrate addition measured after 30 mins | 2016 | European journal of medicinal chemistry, Aug-08, Volume: 118 | Structure-activity relationships of 2-arylquinazolin-4-ones as highly selective and potent inhibitors of the tankyrases. |
| AID9043 | Tested in vitro for cytotoxic activity against lung carcinoma (A-549) cell line | 2000 | Journal of medicinal chemistry, Nov-16, Volume: 43, Issue:23
| 6-Alkylamino- and 2,3-dihydro-3'-methoxy-2-phenyl-4-quinazolinones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. |
| AID673516 | Antiproliferative activity against human COLO205 cells by MTT assay | 2012 | Bioorganic & medicinal chemistry letters, Aug-01, Volume: 22, Issue:15
| InCl3-catalysed synthesis of 2-aryl quinazolin-4(3H)-ones and 5-aryl pyrazolo[4,3-d]pyrimidin-7(6H)-ones and their evaluation as potential anticancer agents. |
| AID94196 | Tested in vitro for cytotoxic activity against P-glycoprotein-expressing epidermoid carcinoma of the nasopharynx(KB-VIN) cell line | 2000 | Journal of medicinal chemistry, Nov-16, Volume: 43, Issue:23
| 6-Alkylamino- and 2,3-dihydro-3'-methoxy-2-phenyl-4-quinazolinones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. |
| AID1153851 | Cytotoxicity against human PC3 cells after 72 hrs by MTT assay | 2014 | Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13
| Synthesis and β-glucuronidase inhibitory activity of 2-arylquinazolin-4(3H)-ones. |
| AID1254452 | Non-Competitive inhibition of Saccharomyces cerevisiae alpha-glucosidase by multiplate reader method using p-nitrophenyl-alpha-D-glucopyranoside as substrate | 2015 | Bioorganic & medicinal chemistry, Dec-01, Volume: 23, Issue:23
| 2-Arylquinazolin-4(3H)-ones: A new class of α-glucosidase inhibitors. |
| AID1391371 | Antiparasitic activity against tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF after 4 days by chlorophenol red-beta-D-galactosidase based assay | 2018 | Bioorganic & medicinal chemistry letters, 05-15, Volume: 28, Issue:9
| One-pot, multicomponent synthesis of 2,3-disubstituted quinazolin-ones with potent and selective activity against Toxoplasma gondii. |
| AID93330 | Tested in vitro for cytotoxic activity against Human ovarian cancer (IA9) cell line | 2000 | Journal of medicinal chemistry, Nov-16, Volume: 43, Issue:23
| 6-Alkylamino- and 2,3-dihydro-3'-methoxy-2-phenyl-4-quinazolinones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. |
| AID96029 | Tested in vitro for cytotoxic activity against epidermoid carcinoma of the nasopharynx(KB) cell line | 2000 | Journal of medicinal chemistry, Nov-16, Volume: 43, Issue:23
| 6-Alkylamino- and 2,3-dihydro-3'-methoxy-2-phenyl-4-quinazolinones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. |
| AID1525652 | Inhibition of GST tagged-TEV cleavage site-fused human recombinant TNKS2 (873 to 1166 residues) expressed in baculovirus infected Sf9 cells assessed as reduction in auto-PARsylation incubated for 90 mins in presence of bio-NAD as co-substrate by TR-FRET a | 2019 | Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
| Discovery and Optimization of 2-Arylquinazolin-4-ones into a Potent and Selective Tankyrase Inhibitor Modulating Wnt Pathway Activity. |
| AID1312675 | Antiproliferative activity against human HT-29 cells at 10 uM by MTS assay | 2016 | European journal of medicinal chemistry, Aug-08, Volume: 118 | Structure-activity relationships of 2-arylquinazolin-4-ones as highly selective and potent inhibitors of the tankyrases. |
| AID1866926 | Inhibition of TNKS2 (unknown origin) | 2022 | Journal of medicinal chemistry, 04-14, Volume: 65, Issue:7
| Small-Molecule Inhibitors of Tankyrases as Prospective Therapeutics for Cancer. |
| AID94200 | Tested in vitro for cytotoxic activity against P-glycoprotein-expressing epidermoid carcinoma of the nasopharynx(KB-VIN) cell line | 2000 | Journal of medicinal chemistry, Nov-16, Volume: 43, Issue:23
| 6-Alkylamino- and 2,3-dihydro-3'-methoxy-2-phenyl-4-quinazolinones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. |
| AID103726 | Tested in vitro for cytotoxic activity against breast cancer (MCF-7) cell line | 2000 | Journal of medicinal chemistry, Nov-16, Volume: 43, Issue:23
| 6-Alkylamino- and 2,3-dihydro-3'-methoxy-2-phenyl-4-quinazolinones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. |
| AID93325 | Tested in vitro for cytotoxic activity against Human ovarian cancer (IA9) cell line | 2000 | Journal of medicinal chemistry, Nov-16, Volume: 43, Issue:23
| 6-Alkylamino- and 2,3-dihydro-3'-methoxy-2-phenyl-4-quinazolinones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. |
| AID95662 | Tested in vitro for cytotoxic activity against epidermoid carcinoma of the nasopharynx(KB) cell line | 2000 | Journal of medicinal chemistry, Nov-16, Volume: 43, Issue:23
| 6-Alkylamino- and 2,3-dihydro-3'-methoxy-2-phenyl-4-quinazolinones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. |
| AID1391369 | Therapeutic index, ratio of TD50 for HFF to IC50 for tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF | 2018 | Bioorganic & medicinal chemistry letters, 05-15, Volume: 28, Issue:9
| One-pot, multicomponent synthesis of 2,3-disubstituted quinazolin-ones with potent and selective activity against Toxoplasma gondii. |
| AID214189 | Tested for inhibition of radioligand colchicine binding to bovine tubulin; ND means No data | 2000 | Journal of medicinal chemistry, Nov-16, Volume: 43, Issue:23
| 6-Alkylamino- and 2,3-dihydro-3'-methoxy-2-phenyl-4-quinazolinones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. |
| AID1525656 | Intrinsic clearance in human liver microsomes assessed per mg protein in presence of NADPH by UPLC analysis | 2019 | Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
| Discovery and Optimization of 2-Arylquinazolin-4-ones into a Potent and Selective Tankyrase Inhibitor Modulating Wnt Pathway Activity. |
| AID1525658 | Selectivity ratio of IC50 for recombinant human full-length Myc/His-tagged Parp-1 expressed in baculovirus infected Sf21 insect cells to IC50 for GST tagged-TEV cleavage site-fused human recombinant TNKS2 (873 to 1166 residues) expressed in baculovirus in | 2019 | Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
| Discovery and Optimization of 2-Arylquinazolin-4-ones into a Potent and Selective Tankyrase Inhibitor Modulating Wnt Pathway Activity. |
| AID1866927 | Inhibition of PARP1 (unknown origin) | 2022 | Journal of medicinal chemistry, 04-14, Volume: 65, Issue:7
| Small-Molecule Inhibitors of Tankyrases as Prospective Therapeutics for Cancer. |
| AID673517 | Antiproliferative activity against human MDA-MB-231 cells by MTT assay | 2012 | Bioorganic & medicinal chemistry letters, Aug-01, Volume: 22, Issue:15
| InCl3-catalysed synthesis of 2-aryl quinazolin-4(3H)-ones and 5-aryl pyrazolo[4,3-d]pyrimidin-7(6H)-ones and their evaluation as potential anticancer agents. |
| AID1525655 | Thermodynamic solubility in phosphate buffer at pH 7.4 at 2 mg incubated under shaking condition for 6 hrs followed by rechecking and readjusting pH to 7.4 and further incubated for 18 hrs by HPLC/UV detection method | 2019 | Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
| Discovery and Optimization of 2-Arylquinazolin-4-ones into a Potent and Selective Tankyrase Inhibitor Modulating Wnt Pathway Activity. |
| AID1312674 | Antiproliferative activity against human HT-29 cells at 100 uM by MTS assay | 2016 | European journal of medicinal chemistry, Aug-08, Volume: 118 | Structure-activity relationships of 2-arylquinazolin-4-ones as highly selective and potent inhibitors of the tankyrases. |
| AID156656 | Tested in vitro for cytotoxic activity against prostate cancer (PC3) cell line | 2000 | Journal of medicinal chemistry, Nov-16, Volume: 43, Issue:23
| 6-Alkylamino- and 2,3-dihydro-3'-methoxy-2-phenyl-4-quinazolinones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. |
| AID1525649 | Selectivity ratio of IC50 for recombinant human full-length Myc/His-tagged Parp-1 expressed in baculovirus infected Sf21 insect cells to IC50 for GST tagged-TEV cleavage site-fused human recombinant TNKS1 (1023 to 1327 residues) expressed in baculovirus i | 2019 | Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
| Discovery and Optimization of 2-Arylquinazolin-4-ones into a Potent and Selective Tankyrase Inhibitor Modulating Wnt Pathway Activity. |
| AID1525657 | Intrinsic clearance in mouse liver microsomes assessed per mg protein in presence of NADPH by UPLC analysis | 2019 | Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
| Discovery and Optimization of 2-Arylquinazolin-4-ones into a Potent and Selective Tankyrase Inhibitor Modulating Wnt Pathway Activity. |
| AID1525651 | Inhibition of GST tagged-TEV cleavage site-fused human recombinant TNKS1 (1023 to 1327 residues) expressed in baculovirus infected Sf9 cells assessed as reduction in auto-PARsylation incubated for 90 mins in presence of bio-NAD as co-substrate by TR-FRET | 2019 | Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
| Discovery and Optimization of 2-Arylquinazolin-4-ones into a Potent and Selective Tankyrase Inhibitor Modulating Wnt Pathway Activity. |
| AID202813 | Tested in vitro for cytotoxic activity against melanoma (SKMEL-2) cell line | 2000 | Journal of medicinal chemistry, Nov-16, Volume: 43, Issue:23
| 6-Alkylamino- and 2,3-dihydro-3'-methoxy-2-phenyl-4-quinazolinones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. |
| AID156643 | Tested in vitro for cytotoxic activity against prostate cancer (PC3) cell line | 2000 | Journal of medicinal chemistry, Nov-16, Volume: 43, Issue:23
| 6-Alkylamino- and 2,3-dihydro-3'-methoxy-2-phenyl-4-quinazolinones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. |
| AID673515 | Antiproliferative activity against human K562 cells by MTT assay | 2012 | Bioorganic & medicinal chemistry letters, Aug-01, Volume: 22, Issue:15
| InCl3-catalysed synthesis of 2-aryl quinazolin-4(3H)-ones and 5-aryl pyrazolo[4,3-d]pyrimidin-7(6H)-ones and their evaluation as potential anticancer agents. |
| AID1391370 | Cytotoxicity against HFF by CellTiter96 AQueous one solution cell proliferation assay | 2018 | Bioorganic & medicinal chemistry letters, 05-15, Volume: 28, Issue:9
| One-pot, multicomponent synthesis of 2,3-disubstituted quinazolin-ones with potent and selective activity against Toxoplasma gondii. |
| AID1656455 | Inhibition of beta-glucuronidase (unknown origin) using p-nitrophenyl-beta-d-glucuronide as substrate after 30 mins | 2020 | European journal of medicinal chemistry, Feb-01, Volume: 187 | Therapeutic significance of β-glucuronidase activity and its inhibitors: A review. |
| AID1866928 | Inhibition of PAPR2 (unknown origin) | 2022 | Journal of medicinal chemistry, 04-14, Volume: 65, Issue:7
| Small-Molecule Inhibitors of Tankyrases as Prospective Therapeutics for Cancer. |
| AID1664159 | Displacement of [3H]NECA from Sprague-Dawley rat striatal membrane A2A adenosine receptor by scintillation counting analysis | | | |
| AID1454077 | Inhibition of Escherichia coli MurA assessed as residual enzyme activity at 100 uM using UDP-GlcNAc and PEP as substrate incubated for 15 mins by Malachite green method | 2017 | Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
| Synthesis and structure-activity relationship study of novel quinazolinone-based inhibitors of MurA. |
| AID1312669 | Inhibition of PARP-1 (unknown origin) using histone as substrate incubated for 1 hr by chemiluminescence assay | 2016 | European journal of medicinal chemistry, Aug-08, Volume: 118 | Structure-activity relationships of 2-arylquinazolin-4-ones as highly selective and potent inhibitors of the tankyrases. |
| AID1454079 | Antibacterial activity against Staphylococcus aureus ATCC 29213 incubated for 18 to 24 hrs by broth microdilution method | 2017 | Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
| Synthesis and structure-activity relationship study of novel quinazolinone-based inhibitors of MurA. |
| AID84368 | Tested in vitro for cytotoxic activity against bone(HOS) cell line | 2000 | Journal of medicinal chemistry, Nov-16, Volume: 43, Issue:23
| 6-Alkylamino- and 2,3-dihydro-3'-methoxy-2-phenyl-4-quinazolinones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. |
| AID101761 | Tested in vitro for cytotoxic activity against breast cancer(MCF-7) cell line | 2000 | Journal of medicinal chemistry, Nov-16, Volume: 43, Issue:23
| 6-Alkylamino- and 2,3-dihydro-3'-methoxy-2-phenyl-4-quinazolinones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. |
| AID1153850 | Inhibition of beta-glucuronidase activity (unknown origin) assessed as p-nitrophenol formation after 30 mins using p-nitrophenyl-beta-D-glucuronide as substrate by spectrophotometry | 2014 | Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13
| Synthesis and β-glucuronidase inhibitory activity of 2-arylquinazolin-4(3H)-ones. |
| AID78981 | Tested in vitro for cytotoxic activity against ileocecal carcinoma (HCT-8) cell line | 2000 | Journal of medicinal chemistry, Nov-16, Volume: 43, Issue:23
| 6-Alkylamino- and 2,3-dihydro-3'-methoxy-2-phenyl-4-quinazolinones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. |
| AID202822 | Tested in vitro for cytotoxic activity against melanoma (SKMEL-2) cell line | 2000 | Journal of medicinal chemistry, Nov-16, Volume: 43, Issue:23
| 6-Alkylamino- and 2,3-dihydro-3'-methoxy-2-phenyl-4-quinazolinones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. |
| AID1664160 | Displacement of [3H]NECA from Sprague-Dawley rat striatal membrane A2A adenosine receptor at 100 uM by scintillation counting analysis relative to control | | | |
| AID1312673 | Inhibition of N-terminal GST-tagged human TNKS-2 (849 to 1166 residues) expressed in in insect sf21 cells at 10 nM preincubated for 2 hrs followed by substrate addition measured after 30 mins | 2016 | European journal of medicinal chemistry, Aug-08, Volume: 118 | Structure-activity relationships of 2-arylquinazolin-4-ones as highly selective and potent inhibitors of the tankyrases. |
| AID1664157 | Displacement of [3H]DPCPX from Sprague-Dawley rat whole brain membrane A1AR by scintillation counting analysis | | | |
| AID1527558 | Inhibition of NLRP3 inflammasome activation in LPS-primed mouse J774A.1 cells assessed as reduction in IL-1beta level at 10 uM preincubated for 1 hr followed by addition of ATP and measured after 30 mins by ELISA method relative to control | 2020 | European journal of medicinal chemistry, Jan-01, Volume: 185 | Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases. |
| AID1312667 | Inhibition of TNKS-1 (unknown origin) using histone as substrate incubated for 30 mins by colorimetric assay | 2016 | European journal of medicinal chemistry, Aug-08, Volume: 118 | Structure-activity relationships of 2-arylquinazolin-4-ones as highly selective and potent inhibitors of the tankyrases. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
| AID540299 | A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis | 2010 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
| Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. |
| AID588519 | A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities | 2011 | Antiviral research, Sep, Volume: 91, Issue:3
| High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |